- $15.25m
- $17.04m
Annual balance sheet for Biomx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 56.3 | 62.1 | 33.3 | 14.9 | 16.9 |
| Net Total Receivables | 0 | 0 | — | 0.574 | 1.17 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 60.7 | 66.6 | 36.9 | 17.6 | 20.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6.66 | 9.83 | 8.65 | 7.4 | 10.5 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 70.4 | 78 | 45.5 | 25 | 43.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.16 | 11 | 7.94 | 11.2 | 8.27 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 12.9 | 30.5 | 24.5 | 21.9 | 19.1 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 57.5 | 47.5 | 21 | 3.08 | 24.1 |
| Total Liabilities & Shareholders' Equity | 70.4 | 78 | 45.5 | 25 | 43.2 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |